DalsnaFinance › IPOs › Alamar Biosciences › IPO
Alamar Biosciences, Inc. completed its initial public offering on NASDAQ on April 17, 2026, pricing at $17.00 a share.
| Ticker | ALMR |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | April 17, 2026 |
| Offering price | $17.00 |
| Shares offered | 11,250,000 |
| Total raised | $191M |
Alamar Biosciences, Inc. sold 11,250,000 shares at $17.00 each on NASDAQ. Multiplied out, that is $191.3 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $191 million total recorded for the deal.
Measured by money raised, Alamar Biosciences, Inc. was tied for the 244th largest (level with 1 other deal) of 473 completed IPOs with a recorded deal size that this site tracks since October 5, 2024. The median deal in the same window raised $200 million.
Among the 342 listings on NASDAQ alone, it is tied for the 176th largest (level with 1 other listing).
April 2026 saw 30 completed IPOs in the site's data; by amount raised, Alamar Biosciences, Inc. was the 17th largest of the 30 deals with a recorded size.
Its $17.00 offer price was tied for the 96th highest (level with 12 other listings) of the 479 listings in the window with a recorded price. A share price on its own says nothing about a company's value; it depends on how many shares exist.
Alamar Biosciences, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Alamar Biosciences, Inc.. This page is general information, not investment advice.